Microdosimetry spectra of the Loma Linda proton beam and relative biological effectiveness comparisons

Medical Physics - Tập 24 Số 9 - Trang 1499-1506 - 1997
G. Coutrakon1, J. Cortese1, A Ghebremedhin1, J. Hubbard1, J. Johanning1, P. Koss1, G. Maudsley1, C. R. Slater1, C. N. ZUCCARELLI1, James Robertson2
1Department of Radiation Medicine, Loma Linda University Medical Center, Loma Linda, California 92354
2Department of Environmental Health, East Carolina University, Greenville, North Carolina 27858

Tóm tắt

Protons have long been recognized as low LET radiation in radiotherapy. However, a detailed account of LET (linear energy transfer) and RBE (relative biological effectiveness) changes with incident beam energy and depth in tissue is still unresolved. This issue is particularly important for treatment planning, where the physical dose prescription is calculated from a RBE using cobalt as the reference radiation. Any significant RBE changes with energy or depth will be important to incorporate in treatment planning. In this paper we present microdosimetry spectra for the proton beam at various energies and depths and compare the results to cell survival studies performed at Loma Linda. An empirically determined biological weighting function that depends on lineal energy is used to correlate the microdosimetry spectra with cell survival data. We conclude that the variations in measured RBE with beam energy and depth are small until the distal edge of the beam is reached. On the distal edge, protons achieve stopping powers as high as 100 keV/μm, which is reflected in the lineal energy spectra taken there. Lineal energy spectra 5 cm beyond the distal edge of the Bragg peak also show a high LET component but at a dose rate 600 times smaller than observed inside the proton field.

Từ khóa


Tài liệu tham khảo

P. Pihet H. G. Menzel R. Schmidt M. Beauduin and A. Wambersie “Biological weighting function for RBE specification of neutron beams ” Radiat. Protect. Dosimetry31 p. 437–442 (1990).

J. M. Slater D. W. Miller and J. O. Archambeau “Development of a hospital‐based proton beam treatment center ” Int. J. Radiat. Oncol. Biol. Phys.14 761–775 (1988).

10.1118/1.596617

AAPM 1983 “Protocol for heavy charged particle beam dosimetry ” American Institute of Physics Report No. 16 1983.

10.1088/0031-9155/40/8/004

V. P. Cosgrove A. C. Aro S. Green M. C. Scott G. C. Taylor D. E. Bonnett and A. Kacperek “Studies relating to 62 MeV proton cancer therapy of the eye ” Radiat. Protect. Dosimetry44 405–409 (1990).

P. J. Kliauga R. D. Colvett Y. M. Lam and H. H. Rossi “The relative biological effectiveness of 160 MeV protons ” Int. J. Radiat. Oncol. Biol. Phys.4 1001–1008 (1978).

10.1016/0273-1177(94)90477-4

H. H. Rossi and M. Zaider Microdosimetry and its Applications(Springer‐Verlag Berlin 1995) p. 10.

J. Fowler Nuclear Particles in Cancer Treatment(Hilger London 1981) pp. 108–109.

See Ref. 9 p. 222.

L. G. Christophorou Atomic and Molecular Radiation Physics(Wiley New York 1971) p. 14.

10.1002/1097-0142(197506)35:6<1664::AID-CNCR2820350628>3.0.CO;2-#

M. R. Raju Heavy Particle Radiotherapy(Academic New York 1980) p. 213.

J. Gueulette V. Gregoire M. Octave‐Prignot and A. Wambersie “Measurements of Radiobiological Effectiveness in the 85 MeV Proton Beam Produced at the Cyclotron CYCLONE of Louvain‐la‐Neuve Belgium ” Radiation Research145 70–74 (1996).